SEPARATION, RELEASE AND CONSULTING SERVICES AGREEMENTSeparation, Release And • May 10th, 2007 • Dyax Corp • Services-commercial physical & biological research • Massachusetts
THIS SEPARATION RELEASE AND CONSULTING SERVICES AGREEMENT (“Agreement”), is entered into as of May 3, 2007, by and between Dyax Corp., a Delaware corporation with a principal place of business at 300 Technology Square, Cambridge, MA 02139 (“Dyax”) and Thomas R. Beck, M.D. of 345 Silver Hill Road, Concord, MA 01742 (“Beck”).
TERMINATION AGREEMENTTermination Agreement • May 10th, 2007 • Dyax Corp • Services-commercial physical & biological research
This Termination Agreement terminates the Amended and Restated Collaboration Agreement dated May 31, 2002, as previously amended (the “Collaboration Agreement”) by and between Genzyme Corporation, with its principal office at 500 Kendall Street, Cambridge, Massachusetts, 02142 (“Genzyme”), and Dyax Corp., with a principal office at 300 Technology Square, Cambridge, Massachusetts, 02139 (“Dyax”), and is effective as of February 20, 2007 (“Termination Effective Date”). Terms not otherwise defined herein shall have the respective meanings attributed to them in the Collaboration Agreement.
